BlackRock Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

BlackRock Group’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$25K	Hold	3,246	–	–	﹤0.01%	2956
2016 Q3	$37K	Hold	3,246	–	–	﹤0.01%	2946
2016 Q2	$40K	Hold	3,246	–	–	﹤0.01%	2949
2016 Q1	$33K	Buy	3,246 +2,347	+261%	+$27.6K	﹤0.01%	2991
2015 Q4	$20K	Hold	899	–	–	﹤0.01%	2944
2015 Q3	$15K	Buy	+899	New	+$18K	﹤0.01%	3006
2015 Q2	–	Sell	-243	Closed	-$6K	–	3016
2015 Q1	$6K	Hold	243	–	–	﹤0.01%	2835
2014 Q4	$5K	Hold	243	–	–	﹤0.01%	2864
2014 Q3	$5K	Sell	243 -6,138	-96%	-$123K	﹤0.01%	2824
2014 Q2	$149K	Buy	+6,381	New	+$158K	﹤0.01%	2528
2013 Q4	–	Sell	-5,919	Closed	-$91K	–	2979
2013 Q3	$91K	Buy	+5,919	New	+$110K	﹤0.01%	2621

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock Group's OMED Position: Q4 2016 in Review

BlackRock Group held its OncoMed Pharmaceuticals, Inc. (OMED) position steady in Q4 2016 at 3,246 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #2956.

BlackRock Group first reported a position in OMED in Q3 2013 and has held it in 11 quarters since. The position peaked at $149K in Q2 2014. 86 funds tracked by Wall St. Rank hold OMED as of Q4 2016.

BlackRock Group held 3,246 shares of OncoMed Pharmaceuticals, Inc. worth $25K as of Q4 2016.
BlackRock Group left its OncoMed Pharmaceuticals, Inc. share count unchanged in Q4 2016.
OncoMed Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2956 holding.
BlackRock Group first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and has held it in 11 quarters since.
BlackRock Group's OncoMed Pharmaceuticals, Inc. position peaked at $149K in Q2 2014.
86 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.